Veligrotug
Product Specifications
CAS Number
2728655-31-8
Target
IGF-1R
Related Pathways
Tyrosine Kinase/Adaptors
Purity
0.998
Bioactivity
Veligrotug is an intravenously administered anti-insulin-like growth factor-1 receptor antibody developed for the treatment of thyroid eye disease (TED) . Veligrotug has demonstrated rapid reductions in diplopia as well as improvements in orbital inflammation, thereby highlighting its potential as a targeted biologic research tool in autoimmune ophthalmopathy.
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS6283500-01 0.2 mL
CD80, CT (CD80, CD28LG, CD28LG1, LAB7, T-lymphocyte activation antigen CD80, Activation B7-1 antigen, BB1, CTLA-4 counter-receptor B7.1, CD80) (AP)
Sign In for Pricing
View Details